Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joseline Ojaimi is active.

Publication


Featured researches published by Joseline Ojaimi.


Mechanisms of Ageing and Development | 1999

Mitochondrial respiratory chain activity in the human brain as a function of age.

Joseline Ojaimi; Colin L. Masters; Ken Opeskin; Penny McKelvie; Edward Byrne

Age-associated changes in mitochondrial respiratory chain activity were investigated in human brain tissue collected at autopsy. Four brain regions, the frontal cortex, superior temporal cortex, cerebellum and putamen, were studied to map any regional variation. A significant decrease in cytochrome c oxidase activity was seen in all regions studied with increasing age (P<0.05). Although a small decrease in succinate dehydrogenase-cytochrome c oxidoreductase and NADH: ubiquinone oxidoreductase activities was observed, this was not statistically significant. This study has shown that the age-related fall in cytochrome c oxidase activity affects the frontal cortex, superior temporal cortex, cerebellum and putamen. The variation in the extent of age-related oxidative phosphorylation decline was striking. We hypothesize that individuals with more severe age-related decline may be predisposed to neuronal dysfunction, whereas individuals with well preserved oxidative phosphorylation may enjoy some degree of neuronal protection.


Calcified Tissue International | 2005

Localization of Pigment Epithelium-Derived Factor in Growing Mouse Bone

Gerald M. Y. Quan; Joseline Ojaimi; Yaping Li; Vicky Kartsogiannis; Hong Zhou; Peter F. M. Choong

Pigment epithelium-derived factor (PEDF) is a potent anti-angiogenic factor found in a wide range of fetal and adult tissues, where it is thought to play a role in the regulation of angiogenesis during development. The temporal expression of PEDF during endochondral bone formation has not previously been reported. In this study, we analysed the expression pattern of PEDF in growing mouse hindlimbs from newborn day one through to maturation at week 9, using immunohistochemistry and in situ hybridization. PEDF expression was demonstrated in chondrocytes within the resting, proliferative and upper hypertrophic zones of the epiphyseal growth plate. The pattern of expression was consistent throughout the developmental stages of the mouse. In addition, PEDF was expressed by osteoblasts lining the bone spicules in the ossification zone of metaphyseal bone, as well as by osteoblasts lining cortical periosteum. These novel results demonstrate that PEDF is developmentally expressed in both cartilage and bone cells during endochondral bone formation, and strongly suggest that it may play a regulatory role in the processes of chondrocyte and osteoblast differentiation, endochondral ossification, and bone remodelling during growth and development of long bones.


Annals of Neurology | 1999

Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease.

Joseline Ojaimi; Colin L. Masters; Catriona McLean; Ken Opeskin; Penny McKelvie; Edward Byrne

This study aims to investigate the cellular distribution of human cytochrome c oxidase (COX) subunit II (CII) and COX subunit IV (CIV) in Alzheimers disease relative to control brains. The levels of CIV and CII proteins in the cerebellar Purkinje cells were reduced in age‐matched controls relative to young controls and in the Alzheimers disease group relative to both age‐matched and young controls. Results suggest that these age‐associated changes are more marked in Alzheimers disease.


Pathobiology | 2002

Resistance of Epiphyseal Cartilage to Invasion by Osteosarcoma Is Likely to Be Due to Expression of Antiangiogenic Factors

Gerald M. Y. Quan; Joseline Ojaimi; A.P. Wijayanthi Nadesapillai; Hong Zhou; Peter F. M. Choong

Objectives: Epiphyseal cartilage is a barrier to osteosarcoma invasion, however the mechanisms behind this resistance remain unclear. The aim of this study was to examine the chronological and spatial patterns of osteosarcoma growth and invasion of local tissue structures including epiphyseal cartilage. Methods: We used an in vivomouse model of osteosarcoma to histologically examine tumors at different stages of disease progression. We compared the pattern of osteosarcoma penetration of epiphyseal cartilage with the expression pattern of two potent mediators of angiogenesis; proangiogenic vascular endothelial growth factor (VEGF) and antiangiogenic pigment epithelium-derived factor (PEDF). Results: Epiphyseal cartilage remained intact across its entire length in all sections examined, despite increasing tumor size as well as intra- and extraosseous destruction. In the most advanced cases, only the proangiogenic lowermost layers of the hypertrophic zone of the growth plate were eroded. This corresponded with the growth plate layers which highly expressed the angiogenic factor VEGF. In contrast, the resting, proliferative and upper hypertrophic layers were resistant to osteosarcoma invasion in all cases. This corresponded to the layers with the highest expression of the potent antiangiogenic factor PEDF. Conclusion: Epiphyseal cartilage is resistant to local invasion by osteosarcoma. The balance of angiogenesis, influenced by pro- and antiangiogenic factors, is likely to play an important role in this resistance.


Cerebrovascular Diseases | 1998

Mitochondrial DNA in Stroke and Migraine with Aura

Joseline Ojaimi; Sophie Katsabanis; Simon Bower; Anita F. Quigley; Edward Byrne

Patients presenting with thrombotic stroke of unexplained etiology and or migraine with aura were screened for mitochondrial (mt) DNA mutations associated with cytopathies given that both migraine and stroke-like episodes are recognised with certain mt DNA mutations. Mutations usually associated with either mitochondrial encephalopathy, lactic acidosis and stroke-like episode, myoclonic epilepsy with ragged red fibres, or those strongly linked to Leber’s hereditary optic neuropathy (LHON) were not detected in patients or controls. However, increased levels of two of the secondary LHON mutations were found. The T→C mutation at nucleotide 4216 was more common than expected in patients aged 35 years or less, as was the 13708 G→A mutation in young stroke patients. This data lends support to the possibility that an accumulation of minor mt DNA mutations may contribute to the pathoaetiology of stroke and migraine with aura in some young patients.


International Seminars in Surgical Oncology | 2006

Outcome of patients with osteosarcoma over 40 years of age: Is angiogenesis a marker of survival?

Eugene T. Ek; Joseline Ojaimi; Yasuyuki Kitagawa; Peter F. M. Choong

BackgroundOsteosarcoma predominantly afflicts young people in their second and third decades of life. When osteosarcoma arises in patients older than 40 years, the prognosis is usually poorer compared to their younger counterparts. Although the clinical, histopathologic features and prognostic indicators are well defined for young patients, much less is known about affected adults. The purpose of this study is to describe our institutions experience with the management of osteosarcoma in patients greater than 40 years and also evaluate, by immunohistochemical analysis, the prognostic significance of microvessel density, as a marker of intratumoural angiogenesis.MethodsA retrospective clinicopathological analysis was performed on 11 patients over the age of 40 years that were treated at our institution between 1996 and 2004. Archival pre-treatment biopsy tissue was retrieved for immunohistochemical staining against two endothelial cell markers (CD31 and CD34) and also against VEGF. Angiogenesis was assessed by determining the intratumoural microvessel density (MVD) and the degree of VEGF expression in these specimens. This was correlated with patient outcome in terms of local recurrence, metastasis and death. Histological results were also compared to a group of patients less than 40 years of age.ResultsOf the 11 patients, 9 were male and 2 were female and the mean age was 58 years (range, 42–85). In 7 patients, osteosarcoma arose secondarily from Pagets disease of the bone. The most common site involved was the humerus (7) followed by the femur (2) then pelvis (1) and ulna (1). At the time of diagnosis, 4 patients had metastatic disease. Preoperative chemotherapy was given to 4 patients, with a good response in 3 patients. Six patients underwent limb-sparing surgery, 4 had amputations and 1 was treated with radiotherapy alone. The mean follow up time was 31.5 months (range, 8–81). At this time, 4 patients (36%) had developed lung metastases and 5 patients (46%) had died. Overall survival was 54.5%. Intratumoural MVD was higher in patients over 40 years, although not statistically significant (p = 0.111, CD31; p = 0.134, CD34). VEGF was uniformly expressed in all sections, however no relationship was found between the degree of expression and patient age.ConclusionThe prognosis for older patients with osteosarcoma is generally poor. Initial presentation is commonly associated with metastatic disease and neoadjuvant chemotherapy is often avoided because of its side effects. Increased intratumoural vascularity may contribute to the poorer prognosis in these patients, however further studies are needed.


Journal of Biochemical and Biophysical Methods | 1997

The polymerase chain reaction in the study of mitochondrial genetics

Robert M. I. Kapsa; Nurjati Siregar; Anita F. Quigley; Joseline Ojaimi; Sophie Katsabanis; Carolyn Sue; Edward Byrne

Since its development in the late 1980s, the polymerase chain reaction (PCR) has revolutionised molecular genetic studies. It has provided direct access to genetic material in quantities sufficient for meaningful analyses to be performed. Adaptations to the basic technique have resulted in a wide range of applications from basic gene amplification to the estimation of DNA species quantities within cells. The study of human mitochondrial genetics is but one of the many disciplines to benefit from the rapid ascension of PCR based technology. In this communication we outline several uses of the PCR technique in the detection, quantification and characterisation of human mitochondrial genetic defects. The data presented in this communication highlight the versatility and applicability of PCR not only to mitochondrial research but to other disciplines of medical research.


Oncology Reports | 2006

Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma

Eugene T. Ek; Joseline Ojaimi; Yasuyuki Kitagawa; Peter F. M. Choong


Journal of the Neurological Sciences | 1996

Mitochondrial DNA polymorphism in substantia nigra

Robert M. I. Kapsa; M.J.Bernadette Jean-Francois; Patcharee Lertrit; Shan Weng; Nurjati Siregar; Joseline Ojaimi; Geoffrey A. Donnan; Colin L. Masters; Edward Byrne


Cerebrovascular Diseases | 1998

Secondary prevention for stroke after CAPRIE and ESPS-2. Opinion 1.

Kameshwar Prasad; Geetha R. Menon; Saad Al-Rajeh; Emmanuel Larbi; Olajide Bademosi; Adnan Awada; Abdullah Yousef; Hussein M. Al-Freihi; Hani Miniawi; H. Taillia; H. Chabriat; A. Kurtz; M. Verin; C. Levy; Katayoun Vahedi; E. Tournier-Lasserve; Marie-Germaine Bousser; Joseline Ojaimi; Sophie Katsabanis; Simon Bower; Anita F. Quigley; Edward Byrne; Hans-Christian Koennecke; Henning Mast; Samuel H. Trocio; Ralph L. Sacco; Weidong Ma; J. P. Mohr; John L.P. Thompson; Franco Giubilei

Collaboration


Dive into the Joseline Ojaimi's collaboration.

Top Co-Authors

Avatar

Peter F. M. Choong

St. Vincent's Health System

View shared research outputs
Top Co-Authors

Avatar

Edward Byrne

St. Vincent's Health System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sophie Katsabanis

St. Vincent's Health System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nurjati Siregar

St. Vincent's Health System

View shared research outputs
Researchain Logo
Decentralizing Knowledge